AU511408B2 - 11-desoxy prostaglandin f2 derivatives - Google Patents

11-desoxy prostaglandin f2 derivatives

Info

Publication number
AU511408B2
AU511408B2 AU24795/77A AU2479577A AU511408B2 AU 511408 B2 AU511408 B2 AU 511408B2 AU 24795/77 A AU24795/77 A AU 24795/77A AU 2479577 A AU2479577 A AU 2479577A AU 511408 B2 AU511408 B2 AU 511408B2
Authority
AU
Australia
Prior art keywords
desoxy
prostaglandin
derivatives
desoxy prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU24795/77A
Other languages
English (en)
Other versions
AU2479577A (en
Inventor
J. Meray J. and Deroy R Buendia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7612942A external-priority patent/FR2349328A1/fr
Priority claimed from FR7701299A external-priority patent/FR2377395A2/fr
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU2479577A publication Critical patent/AU2479577A/en
Application granted granted Critical
Publication of AU511408B2 publication Critical patent/AU511408B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AU24795/77A 1976-04-30 1977-05-02 11-desoxy prostaglandin f2 derivatives Expired AU511408B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7612942A FR2349328A1 (fr) 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments
FRFR7612942 1976-04-30
FRFR7701299 1977-01-18
FR7701299A FR2377395A2 (fr) 1977-01-18 1977-01-18 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
AU2479577A AU2479577A (en) 1978-11-09
AU511408B2 true AU511408B2 (en) 1980-08-21

Family

ID=26219428

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24795/77A Expired AU511408B2 (en) 1976-04-30 1977-05-02 11-desoxy prostaglandin f2 derivatives

Country Status (14)

Country Link
US (1) US4119727A (en, 2012)
JP (1) JPS52148048A (en, 2012)
AR (1) AR222627A1 (en, 2012)
AT (1) AT355739B (en, 2012)
AU (1) AU511408B2 (en, 2012)
CA (1) CA1100493A (en, 2012)
CH (1) CH620675A5 (en, 2012)
DE (1) DE2719244A1 (en, 2012)
DK (1) DK187677A (en, 2012)
GB (1) GB1538842A (en, 2012)
IE (1) IE45141B1 (en, 2012)
LU (1) LU77240A1 (en, 2012)
NL (1) NL7704758A (en, 2012)
SE (1) SE436037B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0282901U (en, 2012) * 1988-12-12 1990-06-27
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20050203081A1 (en) * 2004-02-25 2005-09-15 Jinbo Lee Inhibitors of protein tyrosine phosphatase 1B
WO2005081954A2 (en) 2004-02-25 2005-09-09 Wyeth Inhibitors of protein tyrosine phosphatase 1b
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7906552B2 (en) 2004-08-10 2011-03-15 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
BRPI0605926A2 (pt) * 2005-01-14 2009-05-26 Allergan Inc ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
PT1853271E (pt) * 2005-03-04 2011-01-28 Sucampo Ag Método e composição para o tratamento de doenças vasculares periféricas
DK1960353T3 (da) 2005-11-03 2014-05-26 Allergan Inc Prostaglandiner og analoger som midler til sænkning af intraokulært tryk
WO2009140205A2 (en) * 2008-05-15 2009-11-19 Allergan, Inc. Therapeutic substituted cyclopentanes
BR112015011215B1 (pt) 2012-11-26 2018-11-21 Braskem S.A. Catalisador metaloceno suportado em suporte híbrido, processo de obtenção do mesmo, processo de polimerização para obtenção de um homopolímero ou copolímero de etileno com distribuição de massa molar ampla ou bimodal, uso do catalisador de metalocenosuportado e polímero de etileno com distribuição de massa molar ampla ou bimodal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776940A (en) * 1966-08-09 1973-12-04 G Just Intermediates for producing prostaglandins
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US3794664A (en) * 1972-08-17 1974-02-26 G Just Bicyclo(3.1.0)hexane intermediates for producing prostaglandins f1alpha and f1beta
US4387241A (en) * 1974-11-01 1983-06-07 American Cyanamid Company Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives

Also Published As

Publication number Publication date
DE2719244C2 (en, 2012) 1987-10-15
AT355739B (de) 1980-03-25
NL7704758A (nl) 1977-11-01
GB1538842A (en) 1979-01-24
CH620675A5 (en, 2012) 1980-12-15
JPS6131103B2 (en, 2012) 1986-07-17
AR222627A1 (es) 1981-06-15
CA1100493A (fr) 1981-05-05
AU2479577A (en) 1978-11-09
DK187677A (da) 1977-10-31
IE45141B1 (en) 1982-06-30
SE7704616L (sv) 1977-10-31
IE45141L (en) 1977-10-30
JPS52148048A (en) 1977-12-08
SE436037B (sv) 1984-11-05
DE2719244A1 (de) 1977-11-17
LU77240A1 (en, 2012) 1977-12-13
US4119727A (en) 1978-10-10
ATA310177A (de) 1979-08-15

Similar Documents

Publication Publication Date Title
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU511408B2 (en) 11-desoxy prostaglandin f2 derivatives
AU517829B2 (en) Morphanthridine derivatives
AU504526B2 (en) Pipeazine derivatives
AU504601B2 (en) Prostaglandin derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU506679B2 (en) Prostane derivatives
AU512647B2 (en) Solpenamide derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU508851B2 (en) Prostaglandin derivatives
AU521307B2 (en) Prostaglandin type compounds
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU525965B2 (en) Bicyclic prostaglandin derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives
AU512688B2 (en) Thienyl-and T-aminophenyl-pyrrolidine derivatives
AU495377B2 (en) 3-nitropyrazole derivatives